Table 1 Patient demographics
Patients (n) | 15 |
Age (years) | 41.6 ± 10.3 |
Gender | |
Male/female | 2 (13.3%) / 13 (86.7%) |
BMI Kg/M2 | 23.4(19.4–33.0) |
Tuberous Sclerosis | 1 (6.7%) |
Side of surgery | |
Right/Left | 6 (40%) / 9 (60%) |
Size of tumor (cm) | 7.8 ± 2.8 |
Size of hematoma (cm) | 8.5 ± 3.5 |
Preoperative SCr (umol/L) | 53.1 ± 7.7 |
Preoperative HB (g/L) | 109.3 ± 12 |
Operative time (minute) | 101 ± 15 |
WIT (minute) | 28 ± 5 |
EBL (ml) | 311 ± 217 |
Blood transfusion | 5/15 (33.3%) |
Introperative RBC transfusion (U) | 4 (2–6) |
Introperative Plasma transfusion (ml) | 200 (200–400) |
Postoperative SCr (umol/L) | 55.9 ± 7.3 |
Postoperative HB (g/L) | 98.3 ± 9.4 |
Drainage days | 3 (2–5) |
Postoperative Hospitalization | 4.7 ± 1.1 |
Mean follow-up (month) | 24.1 ± 13.2 |
Complications | |
Perirenal fluid | 1 |
Recurrence | 0 |